Skip to content
Sign In

Main Navigation

James Sharp Logo
  • Individuals
    Individuals

    Choose Your Level of Service

    • Discretionary ServiceDiscretionary Service
    • Execution Only ServiceExecution Only Service

    Investing

    • Inheritance TaxInheritance Tax
  • Charities & Trustees
    Charities & Trustees

    Choose Your Level of Service

    • Discretionary ServiceDiscretionary Service
    • Execution Only ServiceExecution Only Service

  • Companies
    Companies

    Choose Your Level of Service

    • Discretionary ServiceDiscretionary Service
    • Execution Only ServiceExecution Only Service

  • News & Insights
    • News & Insights
    • Current Research Coverage List
  • About Us
    • About Us
    • Our People
  • Conectus Portal
  • Contact Us

Market News - Page 654

1 April 2019

AstraZeneca Plc – Selumetinib gets Breakthrough Therapy Designation

Selumetinib granted US Breakthrough Therapy Designation in neurofibromatosis type 1…

1 April 2019

MJ Gleeson Plc – Statement regarding press speculation

The Board of MJ Gleeson plc (“Gleeson”) notes the recent press speculation and confirms that it has appointed Lazard to explore and advise it on a range of options for Gleeson's Strategic Land business (“Strategic Land”)….

29 March 2019

FireAngel Safety Technology Group Plc – Open Offer of up to 30,034,661 New Ordinary Shares and Placing of New Ordinary Shares at 20 pence per New Ordinary Share

FireAngel (AIM: FA.), one of Europe's leading developers and suppliers of home safety products, announces its proposed placing and open offer to raise approximately £6.0 million to accelerate recovery….

29 March 2019

Merchants Trust – Final Results

Final Results for the year ended 31 January 2019…

29 March 2019

Astrazeneca Plc – Proposed placing of new ordinary shares

AstraZeneca announces today its intention to raise up to approximately $3.5bn (the Placing Proceeds) through a placing of new ordinary shares in the Company (Placing Shares) with both existing and new institutional investors (the Placees) (the Placing)….

29 March 2019

Astrazeneca Plc – AstraZeneca and Daiichi Sankyo enter collaboration for novel HER2-targeting antibody-drug conjugate

AstraZeneca has entered into a global development and commercialisation collaboration agreement with Daiichi Sankyo Company, Limited (Daiichi Sankyo) for trastuzumab deruxtecan (DS-8201), a proprietary antibody-drug conjugate (ADC) and potential new targeted medicine for cancer treatment….

29 March 2019

James Halstead Plc – Interim Results

INTERIM RESULTS FOR THE HALF-YEAR ENDED 31 DECEMBER 2018…

29 March 2019

FireAngel Safety Technology Group Plc – Final Results

FireAngel (AIM: FA.), one of Europe's leading developers and suppliers of home safety products, announces its audited final results for the year ended 31 December 2018…

Posts navigation

  • «
  • 1
  • …
  • 652
  • 653
  • 654
  • 655
  • 656
  • …
  • 874
  • »

Home > Market News > Page 654

James Sharp white Logo
Sign In
Linkedin Icon

The Exchange
5 Bank Street
Bury, Lancashire
BL9 0DN

Tel: 0161 764 4043

Fax: 0161 764 1628

Email: mail@jamessharp.dev.icgonline.co.uk

Linkedin Icon

James Sharp & Co is a trading name
of James Sharp & Co LLP (0C422665)

Members of the LLP are referred to as Partners

  • Downloads & Resources
  • Complaints
  • Financial Compensation Scheme
  • Conectus Portal

  • Cyber Essentials Certification
  • Website Terms & Conditions
  • Privacy Policy
  • Cookie policy
  • [wcc_preference_button]

Email Newsletter Sign-up

Consent(Required)
What we do with you information. Find out more
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

© Copyright 2010-2026. All rights reserved. James Sharp & Co. Authorised & Regulated by the Financial Conduct Authority
Member of the London Stock Exchange - Member of the Aquis Stock Exchange - Member of PIMFA

Website by ICG